The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Nationwide Cancer Genome Screening Project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced colorectal cancer.
 
Takeshi Kato
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma; Yakult Honsha
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Eisai
 
Wataru Okamoto
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Chugai Pharma; Merck Serono; Takeda
Consulting or Advisory Role - NanoCarrier
Research Funding - Dainippon Sumitomo Pharma (Inst); Lilly Japan (Inst); MSD (Inst); NanoCarrier (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Hiroki Hara
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Hiroya Taniguchi
Honoraria - Chugai Pharma; Merck Serono; Otsuka; Taiho Pharmaceutical; Takeda
Research Funding - Boehringer Ingelheim (Inst); MSD (Inst); Otsuka (Inst)
 
Takuro Mizukami
No Relationships to Disclose
 
Tadamichi Denda
No Relationships to Disclose
 
Toshikazu Moriwaki
Honoraria - Chugai Pharma; Merck; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Boehringer Ingelheim (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Taito Esaki
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Lilly Japan; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Satoshi Yuki
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda
 
Eiji Oki
Speakers' Bureau - Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Takeshi Kajiwara
No Relationships to Disclose
 
Toshihiro Kudo
No Relationships to Disclose
 
Daisuke Naruge
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Hisamitsu Pharmaceutical (Inst); J-Pharma (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Nippon Kayaku (Inst); Novartis (Inst); OncoTherapy Science (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Torii Pharmaceutical (Inst); Yakult Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
 
Takao Tamura
No Relationships to Disclose
 
Satoshi Fujii
No Relationships to Disclose
 
Toshihiko Doi
Consulting or Advisory Role - AstraZeneca; Bayer Yakuhin; Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; MSD; Nippon Boehringer Ingelheim; Novartis; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Eisai (Inst); Janssen (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sanofi (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Atsushi Ohtsu
Employment - Celgene (I)
Research Funding - Bristol-Myers Squibb
 
Kohei Shitara
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Novartis; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Takayuki Yoshino
Research Funding - Sumitomo Dainippon (Inst)